Tala Shekarkhand

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Tala Shekarkhand

Mar 11, 2025, 09:06 | Blog

Saad Z. Usmani: Restarting Teclistamab and Talquetamab After Prolonged Dose

Saad Z. Usmani, Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center, posted…

Sep 21, 2024, 12:42 | Insight

Myeloma Paper of the Day, September 21st, suggested by Robert Orlowski

Robert Orlowski shared on X: “Myeloma Paper of the Day: Colesevelam appears to be a highly…

Jul 28, 2024, 12:28 | Insight

Ross Firestone: Antigen escape with BCMA-targeting therapies in multiple myeloma

Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared a post on X…

Jun 3, 2024, 22:00 | Insight

Myeloma Paper of the Day, June 3rd, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Comparison of infectious complications with…

May 12, 2024, 13:01 | Insight

Myeloma Paper of the Day, May 12th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023